bioAffinity Technologies, Inc. BIAF
NASDAQ · United States · Health Technology
$6.06-0.09 (-1.46%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -9.60 | -31.50 | +69.5% | $1.51M | -11.2% | -7.5%$7.95→$7.35 |
| Q3 2025 | 2025-11-14 | -71.10 | -40.50 | -75.6% | — | — | -16.0%$28.20→$23.70 |
| Q2 2025 | 2025-08-14 | -76.50 | -45.00 | -70.0% | — | — | — |
| Q1 2025 | 2025-05-15 | -72.00 | -72.00 | 0.0% | — | — | — |
| Q4 2024 | 2025-03-31 | -94.50 | -63.00 | -50.0% | — | — | — |
| Q3 2024 | 2024-11-14 | -72.00 | -67.50 | -6.7% | — | — | — |
| Q2 2024 | 2024-08-14 | -85.50 | -76.50 | -11.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.